<- Go Home

Atrys Health, S.A.

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic counselling; and diagnostic reports and genetic tests. It also provides telemedicine services, such as teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; prevention plans for companies, which includes training plans on occupational risk prevention; Smart Data, a technological database for healthcare; and research and development services. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.

Market Cap

EUR 214.1M

Volume

66.9K

Cash and Equivalents

EUR 13.1M

EBITDA

EUR 6.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 24.9M

Profit Margin

17.27%

52 Week High

EUR 3.59

52 Week Low

EUR 2.48

Dividend

N/A

Price / Book Value

1.41

Price / Earnings

-3.86

Price / Tangible Book Value

-4.25

Enterprise Value

EUR 458.4M

Enterprise Value / EBITDA

40.08

Operating Income

-EUR 10.4M

Return on Equity

27.46%

Return on Assets

-1.21

Cash and Short Term Investments

EUR 13.6M

Debt

EUR 257.9M

Equity

EUR 152.0M

Revenue

EUR 144.3M

Unlevered FCF

-EUR 117.6M

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches